06/04/2024
China has transferred the management of human genetic resources to the National Health Commission, aiming to streamline regulations and foster biotech innovation by balancing oversight and reducing bureaucratic burdens. This shift is expected to enhance international collaboration, attract foreign investment, and expedite drug development in China.